JEFFREY LEIDEN

Profile

First Name

: JEFFREY

Middle Name

:

Last Name

: LEIDEN

Related Companies
Titles
Company Name
Related People
DIRECTOR
LYCERA CORP
KRISTINA BUROW, KRISTINA BURROW, DAVID CANTER, STEVE GILLIS, STEVEN GILLIS, GARY GLICK, GARY D. GLICK, MICHAEL HAYDEN, ROBERT KAMEN, NINA KJELLSON, TIM MAYLEBEN, TIMOTHY MAYLEBEN, KATHLEEN M. METTERS, PAUL SEKHRI, MICHAEL STEINMETZ
DIRECTOR
CATABASIS PHARMACEUTICALS INC
KENNETH BATE, JOANNE T. BECK, FRED CALLORI, NOAH CLAUSER, HUGH COLE, JOANNE C. DONOVAN, NICHOLAS GALAKATOS, JEAN GEORGE, BEN HARSHBARGER, MICHAEL JIROUSEK, MICHAEL D. KISHBAUCH, ANDREW KOMJATHY, GREGG LAPOINTE, RON LAUFER, MAGGIE LEFLORE, JILL MILNE, JILL C. MILNE, ANDREW NICHOLS, MICHAEL ROSS, IAN C. SANDERSON, CHRIS THOMAJAN, CHRISTOPHER Z. THOMAJAN, JONATHAN VIOLIN
DIRECTOR
TYRX PHARMA INC
EDWARD CAHILL, CHARLES CAHN, WILLIAM G. DEMPSEY, WILLIAM EDELMAN, MICHAEL T. HEFFERNAN, MIKE HEFFERNAN, RAY IMP, JEFF LEIDEN, ARIKHA MOSES, ARTHUR PAPPAS, SCOTT REQUADT, ROBERT S. WHITE, WILLIAM YOUNG
DIRECTOR
BIOLEX THERAPEUTICS, INC.
W. THOMAS AMICK, KEVIN BITTERMAN, DAVID CASTALDI, DAVID L. CASTALDI, DENNIS J. DOUGHERTY, KURT GRAVES, JEFF LEIDEN, P. SHERRILL NEFF, LIZA PAGE NELSON, LIZA PAGE NELSON, DALE A. SANDER, DAVID SPENCER, JAN P. TUREK, KLAUS VEITINGER, GLEN WILLIAMS
DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.
DAVID E. ANDERSON, JEFF BAXTER, ADAM BUCKLEY, KEVIN FORREST, STEPHEN GILLIS, STEVE GILLIS, STEVEN GILLIS, MARC J. KIRCHMEIER, EGIDIO NASCIMENTO, SCOTT ROCKLAGE, MICHAEL STEINMETZ, STEVE VIGNAU, STEVEN VIGNAU
DIRECTOR
CASANA CARE, INC.
DAVID BORKHOLDER, STEPHEN BRUSO, NICHOLAS CONN, NICHOLAS J. CONN, ROBERT GIBBONS, OLIVIA LEW, AUSTIN MCCHORD, PAUL SAGAN, KHAN SIDDIQUI, MICHAEL SONNENDECKER
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
CHARLES BAUM, CHARLES M. BAUM, CHUCK BAUM, M. CHARLES BAUM, JILL CARROLL, SHELLEY CHU, GARY D GLICK, GARY D. GLICK, CARL GORDON, JASON HAAS, PAULINA HILL, LORENCE KIM, NAN LI, CAROLYN NG, VALERIE ODEGARD, KSENIJA PAVLETIC, IAN SMITH, LAN F. SMITH, NIA TATSIS, TIMOTHY WALBERT
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-06-16 
2024-08-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2024-01-02
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-04 
2023-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2022-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-13 
2022-01-24
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-04 
2011-12-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-12-06 
2011-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-03 
2011-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-17 
2011-06-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-05-27 
2010-12-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-23 
2010-04-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-07 
2009-04-15
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-04-07